Trial
NCT02315157
Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Collaborators
—
Condition
Multiple Myeloma
Intervention
Bendamustine
Why stopped
Withdrawn by PI
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-15